Revolution Medicines, Inc. RVMD
161.20 USD +1.77 (+1.11%)
Regular-session close
162.08 +0.88 +0.55%
After hours · Nov 20, 6:57 PM ET
160.22 Day range 169.51
69.88 52-week range 221.15
- YTD
- +102.39%
- 1 year
- +130.68%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -1.18B | -689.52M | -487.19M | -258.28M | -188.01M | |
| -1.13B | -600.09M | -436.37M | -248.71M | -187.09M | |
| -5.95 | -3.58 | -3.86 | -3.08 | -2.57 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 388.60M | 546.76M | 699.18M | 163.15M | 110.23M | |
| 2.35B | 2.56B | 2.06B | 811.93M | 737.99M | |
| 723.21M | 293.10M | 235.51M | 126.74M | 135.42M | |
| 427.15M | 135.84M | 87.94M | 64.20M | 66.63M | |
| 1.63B | 2.27B | 1.83B | 685.19M | 602.57M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -897.74M | -557.44M | -350.57M | -224.40M | -147.18M | |
| 118.06M | -554.39M | -342.60M | -24.12M | -142.12M | |
| 621.52M | 959.41M | 1.23B | 301.43M | 294.18M | |
| -15.99M | -10.31M | -7.73M | -10.82M | -6.53M | |
| -158.16M | -152.42M | 536.03M | 52.91M | 4.88M |
